“Drug makers are making more bets on the nascent field of digital medicine. The latest example: Click Therapeutics announced Monday that it grabbed a $17 million investment led by Sanofi Ventures, the Cambridge, MA-based venture capital arm of the French pharmaceutical giant. [Read more…] about Sanofi Ventures leads $17M investment in Click Therapeutics, finalist @ 2017 Brainnovations Pitch Contest
A DISCUSSION WITH EVE MARDER, MICHAEL MERZENICH AND CARLA SHATZ (2016 KAVLI PRIZE IN NEUROSCIENCE):
“Our view of the brain as something constantly shaped by thought and experience is only a few decades old, yet it has profoundly influenced how we teach and treat, raise our young and care for the old.
Eve Marder, Michael Merzenich and Carla Shatz are three researchers who, in very different ways, have revealed that the brain is highly changeable, or plastic. [Read more…] about Three pioneers of neuroplasticity research discuss the present and future of rewiring the brain
“Akili Interactive Labs, Inc. (“Akili”), a digital medicine company developing novel, non-pharmacological therapeutics and diagnostics for cognitive disorders, today announced an $11.9 million expansion of its recent Series B financing. [Read more…] about Akili raises an additional $11.9M; brings Amgen, Merck, Pfizer and Shire to the digital medicine table
“The blood-brain barrier is selectively permeable and blocks unwanted molecules from entering into the brain. The selectivity is achieved [Read more…] about Brain Damage, Therapeutics and the Blood-Brain Barrier